ELION THERAPEUTICS Trademark
Trademark Overview
On Wednesday, December 6, 2023, a trademark application was filed for ELION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ELION THERAPEUTICS trademark a serial number of 98301402. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, July 5, 2024. This trademark is owned by Sfunga Therapeutics, Inc.. The ELION THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the disease state and treatment of invasive fungal infections and invasive fungal disease
General Information
Serial Number | 98301402 |
Word Mark | ELION THERAPEUTICS |
Filing Date | Wednesday, December 6, 2023 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Friday, July 5, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Pharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the disease state and treatment of invasive fungal infections and invasive fungal disease |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, December 6, 2023 |
Primary Code | 042 |
First Use Anywhere Date | Wednesday, January 10, 2024 |
First Use In Commerce Date | Wednesday, January 10, 2024 |
Trademark Owner History
Party Name | ELION THERAPEUTICS, INC. |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 03 - Corporation |
Address | NEW YORK, NY 10010 |
Party Name | Sfunga Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10010 |
Trademark Events
Event Date | Event Description |
Wednesday, December 6, 2023 | NEW APPLICATION ENTERED |
Sunday, March 3, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, May 16, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Thursday, May 23, 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
Thursday, May 23, 2024 | USE AMENDMENT FILED |
Thursday, May 23, 2024 | TEAS AMENDMENT OF USE RECEIVED |
Friday, July 5, 2024 | USE AMENDMENT ACCEPTED |
Friday, July 5, 2024 | NON-FINAL ACTION WRITTEN |
Friday, July 5, 2024 | NON-FINAL ACTION E-MAILED |
Friday, July 5, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, July 5, 2024 | ASSIGNED TO EXAMINER |
Tuesday, September 3, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Tuesday, September 3, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |